Mastrapasqua Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $2.69M | Sell |
7,743
-150
| -2% | -$52.2K | 0.32% | 65 |
|
|
2023
Q2 | $2.78M | Sell |
7,893
-28
| -0.4% | -$9.85K | 0.31% | 65 |
|
|
2023
Q1 | $2.5M | Buy |
7,921
+348
| +5% | +$110K | 0.31% | 68 |
|
|
2022
Q4 | $2.19M | Buy |
7,573
+776
| +11% | +$224K | 0.29% | 77 |
|
|
2022
Q3 | $1.97M | Buy |
6,797
+1,335
| +24% | +$387K | 0.28% | 78 |
|
|
2022
Q2 | $1.54M | Buy |
5,462
+376
| +7% | +$106K | 0.21% | 92 |
|
|
2022
Q1 | $1.33M | Buy |
+5,086
| New | +$1.33M | 0.15% | 108 |
|
|
2021
Q4 | – | Sell |
-10,184
| Closed | -$1.85M | – | 147 |
|
|
2021
Q3 | $1.85M | Sell |
10,184
-48
| -0.5% | -$8.71K | 0.2% | 94 |
|
|
2021
Q2 | $2.06M | Buy |
10,232
+91
| +0.9% | +$18.3K | 0.22% | 86 |
|
|
2021
Q1 | $2.18M | Buy |
10,141
+755
| +8% | +$162K | 0.25% | 84 |
|
|
2020
Q4 | $2.22M | Sell |
9,386
-46
| -0.5% | -$10.9K | 0.29% | 75 |
|
|
2020
Q3 | $2.57M | Sell |
9,432
-89
| -0.9% | -$24.2K | 0.36% | 70 |
|
|
2020
Q2 | $2.76M | Buy |
9,521
+660
| +7% | +$192K | 0.43% | 64 |
|
|
2020
Q1 | $2.11M | Buy |
8,861
+821
| +10% | +$195K | 0.41% | 63 |
|
|
2019
Q4 | $1.76M | Buy |
+8,040
| New | +$1.76M | 0.29% | 79 |
|